Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | PL-DI | CTRPv2 | pan-cancer | AAC | 0.0042 | 0.9 |
mRNA | BRD6340 | CTRPv2 | pan-cancer | AAC | -0.0046 | 0.9 |
mRNA | ABT-737 | CTRPv2 | pan-cancer | AAC | -0.0048 | 0.9 |
mRNA | BI-2536 | GDSC1000 | pan-cancer | AAC | 0.0067 | 0.9 |
mRNA | BRD-A86708339 | CTRPv2 | pan-cancer | AAC | -0.0063 | 0.9 |
mRNA | STF-31 | CTRPv2 | pan-cancer | AAC | 0.0043 | 0.9 |
mRNA | VX-702 | GDSC1000 | pan-cancer | AAC | -0.0043 | 0.9 |
mRNA | tubastatin A | CTRPv2 | pan-cancer | AAC | 0.006 | 0.9 |
mRNA | staurosporine | CTRPv2 | pan-cancer | AAC | -0.0081 | 0.9 |
mRNA | RO4929097 | CTRPv2 | pan-cancer | AAC | 0.0059 | 0.9 |